NCT04610749View on ClinicalTrials.gov

Diabetic Retinopathy as a Marker of Cognitive Dysfunction and Depression

CompletedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

February 25, 2022

Study Completion Date

February 25, 2022

Conditions
Diabetic RetinopathyDepressionCognitive ImpairmentCognitive Dysfunction
Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Region of Southern Denmark

OTHER

NCT04610749 - Diabetic Retinopathy as a Marker of Cognitive Dysfunction and Depression | Biotech Hunter | Biotech Hunter